Marjolein S de Bruin-Weller

51PUBLICATIONS
154CO-AUTHORS
Gene and molecular therapyAllergyPharmacogenomicsGlycoconjugatesAdolescent health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (51)

|Aug 07, 2026
Simulating real-world abrocitinib use in atopic dermatitis: results from JADE REAL.

|Jul 16, 2026
Impact of Dupilumab and Upadacitinib Treatment on Epigenetic and Transcriptomic Alterations in Skin-Homing T Cells of Atopic Dermatitis Patients.

|Jun 01, 2026
Benefit-risk profile comparison between dupilumab and upadacitinib: a structured benefit-risk assessment of the Heads Up trial.

|Jan 21, 2026
Dupilumab Treatment Up to 5 Years Shows No Clinically Meaningful Changes in Laboratory Parameters in Adults with Moderate-to-Severe Atopic Dermatitis.

Eric L Simpson, Robert Bissonnette, Mette Deleuran

|Dec 09, 2025
Drug Survival in Atopic Dermatitis: Comparison of Biologics and JAK Inhibitors in the BioDay Registry.

Lian F van der Gang, Celeste M Boesjes, Nicolaas P A Zuithoff

|Sep 24, 2025
Biologics to Treat Atopic Dermatitis: Effectiveness, Safety, and Future Directions.

Marjolein S de Bruin-Weller, Celeste M Boesjes, Roselie A Achten

Pageof 9

Frequent Collaborators

12 joint publications

Judith Thijs

12 joint publications

Daphne S Bakker

7 joint publications

Marlies de Graaf

6 joint publications

Coco Dekkers